Market Overview

Benzinga's Top Initiations

Related LJPC
La Jolla (LJPC) is Oversold: Can It Recover?
Jefferies Initiates La Jolla Pharma With Buy
Related DRII
Events for the Week of Aug. 29-Oct. 3
Events for the Week of Sept. 15-19th

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

DateFirmActionFromTo
Aug 2014JefferiesInitiates Coverage onBuy
May 2014WainwrightInitiates Coverage onBuy
Mar 2014

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (LJPC + DRII)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters